• Mon news: Ventyx gets boost from Sanofi. PhRMA IRA legal challenge gets new life. AZ breast cancer drug disappoints. Teva’s once-monthly schizophrenia med. AZ gets FDA approval for first self-administered flu vaccine. See more on our front page

FDA Approves Another Weight Loss Drug

Quote

Anonymous

Guest
February 22, 2012 (Updated February 23, 2012) (Silver Spring, Maryland) — The Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee [1,2] voted overwhelmingly in favor of approving the obesity drug Qnexa (Vivus, Mountain View, CA), a combination of phentermine and controlled-release topiramate [3].

If measly lorcaserin even gets approved by a super slim margin, it will have to compete against this one before it even has a chance. Once again Eisai shows what a shining star it is in business and product development. And it only tool a $50 Million deposit.

All executives please dont forget: "Its all the reps' fault!"
 

<



Anonymous said:
February 22, 2012 (Updated February 23, 2012) (Silver Spring, Maryland) — The Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee [1,2] voted overwhelmingly in favor of approving the obesity drug Qnexa (Vivus, Mountain View, CA), a combination of phentermine and controlled-release topiramate [3].

If measly lorcaserin even gets approved by a super slim margin, it will have to compete against this one before it even has a chance. Once again Eisai shows what a shining star it is in business and product development. And it only tool a $50 Million deposit.

All executives please dont forget: "Its all the reps' fault!"
Click to expand...

This is old news and it is a great sign for Eisai. You should be thankful for this great news.
 












I want to get a job in business development at any other company and then engage Eisai in a negotiation. I could lie by the pool while they tripped over themselves to send term sheets agreeing to the most ridiculous things imaginable.
 




























Anonymous said:
February 22, 2012 (Updated February 23, 2012) (Silver Spring, Maryland) — The Food and Drug Administration (FDA) Endocrinologic and Metabolic Drugs Advisory Committee [1,2] voted overwhelmingly in favor of approving the obesity drug Qnexa (Vivus, Mountain View, CA), a combination of phentermine and controlled-release topiramate [3].

If measly lorcaserin even gets approved by a super slim margin, it will have to compete against this one before it even has a chance. Once again Eisai shows what a shining star it is in business and product development. And it only tool a $50 Million deposit.

All executives please dont forget: "Its all the reps' fault!"
Click to expand...
I have take Topamax(topiramate) to prevent Migraines for nearly 15 years now. One of the side effects is weight loss. I have a very small appetite. Phentermine did not have to be combined with Topamax because Topamax works so well by itself. Another side effect of Topamax is memory loss. I often forget to make my calls every day!!!!
 




































Similar threads

FDA approves Eli Lilly's Alzheimer’s drug that slows memory decline
Replies
2
Views
319
Eisai
anonymous
If the FDA approves Biogen’s Alzheimer’s treatment, I won’t prescribe it
Replies
0
Views
652
Eisai
anonymous
FDA Approves Generic Aloxi
Replies
12
Views
2K
Eisai
Anonymous
The end of the beginning: Lilly execs eye top spot in burgeoning Alzheimer's market after Kisunla's FDA approval | Fierce Pharma
Replies
5
Views
508
Eisai
anonymous
Biogen Shares Fall After FDA Approval Of Alzheimer's Drug Leqembi | AfterMarkets
Replies
2
Views
960
Eisai
anonymous
Top Bottom
Back
Quote